FDA clears MedPhoton's CBCT system

By AuntMinnie.com staff writers

September 5, 2019 -- Austrian conebeam CT (CBCT) technology developer MedPhoton has received 510(k) clearance from the U.S. Food and Drug Administration (FDA) for its ImagingRing CBCT system.

MedPhoton has a partnership with Mevion Medical Systems, and ImagingRing will now be available to U.S. users of that company's S250i proton therapy system, Mevion said.

The ImagingRing CBCT scanner features a 102-cm bore with ceiling rail mounting; it was integrated into Mevion's S250i system at Maastro Proton Therapy in Maastricht, the Netherlands, and has been in clinical use there since February.

Copyright © 2019 AuntMinnie.com

To read this and get access to all of the exclusive content on AuntMinnie.com create a free account or sign-in now.

Member Sign In:
MemberID or Email Address:  
Do you have a AuntMinnie.com password?
No, I want a free membership.
Yes, I have a password:  
Forgot your password?
Sign in using your social networking account:
Sign in using your social networking